Fmoc-alpha-Me-D-Val-OH

Fmoc-alpha-Me-D-Val-OH is an N-Fmoc-protected, stereodefined amino acid derivative featuring a D-configured valine backbone bearing an alpha-methyl substituent and a free C-terminal carboxylic acid. The Fmoc carbamate masks the amino functionality for base-compatible peptide coupling workflows, while the side-chain isopropyl group of the valine moiety provides hydrophobic character that can influence conformational preferences in peptide and peptidomimetic scaffolds. The additional alpha-methyl stereocenter increases steric differentiation at the backbone, enabling incorporation of constrained residues that can modulate backbone torsion and protease recognition. The combination of a robust Fmoc group and an unprotected carboxylic acid makes the compound well suited as a chiral building block and synthetic intermediate for downstream amino acid derivatization and peptide assembly.

1. Peptide Synthesis

Fmoc-alpha-Me-D-Val-OH is applied in solid-phase peptide synthesis and related protected amino acid workflows where orthogonal N-protection is required for sequential chain elongation. The Fmoc-protected amine enables controlled deprotection and subsequent coupling, while the free carboxylic acid participates in peptide bond formation using standard coupling chemistries compatible with sterically hindered residues. The D-configuration and alpha-methyl substitution introduce stereochemical control at the backbone, supporting the construction of peptides with defined chirality and altered conformational behavior. The resulting peptide products can be used as research-grade substrates for studying backbone effects on folding, stability, and sequence-dependent reactivity.

2. Peptidomimetics And SAR

Fmoc-alpha-Me-D-Val-OH is used in peptidomimetic construction and structure-activity relationship studies where backbone modification is leveraged to tune hydrophobic packing and proteolytic resistance. The valine-derived isopropyl side chain and the alpha-methyl group create a sterically constrained residue that can mimic or perturb natural amino acid geometry in bioactive peptide scaffolds. The Fmoc handle supports incorporation into analog libraries, enabling systematic variation of stereochemistry and backbone substitution patterns during medicinal chemistry exploration. The carboxylic acid functionality supports further derivatization into amide-linked fragments, enabling downstream generation of SAR-focused analogs and fragment-based libraries.

3. Chiral Building Block Synthesis

Fmoc-alpha-Me-D-Val-OH serves as a chiral amino acid intermediate for stereoselective synthesis routes that require a D-configured, alpha-disubstituted backbone. The presence of a single, well-defined stereocenter at the alpha position together with the D-valine configuration provides a reproducible stereochemical motif for constructing higher-order chiral intermediates. The Fmoc-protected nitrogen can be carried through multi-step sequences as a stable protecting group, while the free carboxyl group can be converted into activated esters or amide-forming derivatives for controlled coupling chemistry. Downstream use includes preparation of non-natural amino acid derivatives, constrained backbone building blocks, and stereochemically defined fragments for fine chemical synthesis.

4. Side-Chain Functionalization

Fmoc-alpha-Me-D-Val-OH is suitable for side-chain and backbone functionalization strategies in amino acid derivatization programs that require a protected amine and a reactive acid handle. The carboxylic acid can be transformed into amide, ester, or activated intermediates to enable attachment of tags, linkers, or solubilizing groups while maintaining the Fmoc protection for orthogonal handling. The alpha-methyl substitution can influence subsequent functional group installation by altering steric accessibility near the backbone, which may be relevant when generating constrained analogs for chemical biology probes. The stereodefined D-valine framework supports consistent reactivity patterns during derivatization and can be used to generate functionalized amino acid derivatives for downstream conjugation and scaffold diversification.

5. Protein Engineering

Fmoc-alpha-Me-D-Val-OH is employed in protein engineering and chemical protein modification workflows where incorporation of non-natural residues can modulate local structure and interaction surfaces. The Fmoc-protected amino acid format supports peptide or protein fragment assembly routes that use protected building blocks to introduce defined stereochemistry into engineered sequences. The D-configuration and alpha-methyl backbone substitution can be used to probe how steric constraints and stereochemical inversion affect folding propensity, binding interfaces, and resistance to enzymatic processing. The free carboxyl group enables formation of defined linkages in engineered polypeptide constructs, supporting generation of research materials for mapping sequence-dependent behavior in protein-like systems.

6. Pharmaceutical Manufacturing Intermediate

Fmoc-alpha-Me-D-Val-OH is relevant to pharmaceutical manufacturing and process chemistry as a protected amino acid intermediate for producing peptide-based intermediates and peptidomimetic building blocks under controlled synthetic sequences. The Fmoc carbamate provides a practical N-protection strategy for stepwise assembly, while the unmasked carboxylic acid supports conversion into coupling-ready derivatives during manufacturing of protected peptide segments. The stereochemical fidelity of the D-configured, alpha-methylated residue supports reproducible incorporation into drug discovery and development candidates that require defined stereochemistry at the backbone. The compound's compatibility with standard peptide coupling paradigms and downstream derivatization into amide-linked intermediates makes it suitable for industrial fine chemical synthesis routes where chiral amino acid building blocks are required.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

3. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)